Clinical trial
Sep 2026
An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.
It is suggested that psilocybin therapy may be safe, tolerable, and preliminarily efficacious for treating depression in BD-II, but randomized controlled trials are needed to confirm efficacy and optimize protocols.
Amanda E. Downey, B. Szigeti, Ellen R. Bradley et al.
· Journal of Clinical Psychiat... · 0 citations